A single dose of eculizumab terminated life-threatening haemolysis in idiopathic IgM-mediated warm autoimmune haemolytic anaemia: A case report

Mamta Garg; Siddharth Agarwal; Mohammed Altohami

doi:10.1111/bjh.18011

King's College London

King's main site

Research portal

A single dose of eculizumab terminated life-threatening haemolysis in idiopathic IgM-mediated warm autoimmune haemolytic anaemia: A case report

Research output: Contribution to journal › Letter › peer-review

Mamta Garg, Siddharth Agarwal, Mohammed Altohami

Original language	English
Pages (from-to)	e28-e31
Journal	British Journal of Haematology
Volume	197
Issue number	2
Early online date	6 Jan 2022
DOIs	https://doi.org/10.1111/bjh.18011
Accepted/In press	8 Dec 2021
E-pub ahead of print	6 Jan 2022
Published	Apr 2022
Additional links	Link to publication in Scopus

Bibliographical note

Funding Information: Mamta Garg declares travel support to attend educaional meetings from BMS, Takeda and Janssen, has been on advisory boards for Takeda, Sanofi, Amgen, Novartis and Janssen and has received a research grant from Janssen. Siddharth Agarwal and Mohammed Altohami have no conflicts of interest to declare.

King's Authors

Siddharth Agarwal (Engineering, Cancer Imaging)

View graph of relations

King's College London - Homepage

A single dose of eculizumab terminated life-threatening haemolysis in idiopathic IgM-mediated warm autoimmune haemolytic anaemia: A case report

Bibliographical note

King's Authors

By the same authors

With some of the same researchers

From the same journal